10x Genomics Inc (NASDAQ: TXG) is 3.41% higher on its value in year-to-date trading and has touched a low of $12.95 and a high of $51.22 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TXG stock was last observed hovering at around $14.81 in the last trading session, with the day’s gains setting it 0.04%.
Currently trading at $14.85, the stock is -2.29% and -0.80% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.34 million and changing 0.27% at the moment leaves the stock -25.25% off its SMA200. TXG registered -64.27% loss for a year compared to 6-month loss of -25.45%. The firm has a 50-day simple moving average (SMA 50) of $14.9901 and a 200-day simple moving average (SMA200) of $19.979626.
The stock witnessed a 0.81% gain in the last 1 month and extending the period to 3 months gives it a -1.66%, and is -1.53% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.67% over the week and 6.87% over the month.
10x Genomics Inc (TXG) has around 1259 employees, a market worth around $1.80B and $629.74M in sales. Profit margin for the company is -28.99%. Distance from 52-week low is 14.67% and -71.01% from its 52-week high. The company has generated returns on investments over the last 12 months (-22.84%).
with sales reaching $164.98M over the same period.The EPS is expected to grow by 35.06% this year, but quarterly earnings will post -1.29% year-over-year. Quarterly sales are estimated to shrink -10.33% in year-over-year returns.
10x Genomics Inc (TXG) Top Institutional Holders
379.0 institutions hold shares in 10x Genomics Inc (TXG), with institutional investors hold 100.09% of the company’s shares. The shares outstanding are 106.98M, and float is at 100.23M with Short Float at 6.59%. Institutions hold 97.93% of the Float.
The top institutional shareholder in the company is FMR LLC with over 13.01 million shares valued at $253.05 million. The investor’s holdings represent 10.8971% of the TXG Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 10.19 million shares valued at $198.18 million to account for 8.5341 of the shares outstanding. The other top investors are ARK INVESTMENT MANAGEMENT LLC which holds 9.31 million shares representing 7.8009% and valued at over $181.15 million, while BLACKROCK INC. holds 5.3542 of the shares totaling 6.39 million with a market value of $124.34 million.
10x Genomics Inc (TXG) Insider Activity
The most recent transaction is an insider sale by Saxonov Serge, the company’s Chief Executive Officer. SEC filings show that Saxonov Serge sold 6,693 shares of the company’s common stock on Nov 22 ’24 at a price of $13.69 per share for a total of $91612.0. Following the sale, the insider now owns 0.87 million shares.
10x Genomics Inc disclosed in a document filed with the SEC on Nov 22 ’24 that Hindson Benjamin J.sold a total of 5,807 shares of the company’s common stock. The trade occurred on Nov 22 ’24 and was made at $13.69 per share for $79485.0. Following the transaction, the insider now directly holds 0.34 million shares of the TXG stock.
Still, SEC filings show that on Nov 22 ’24, Hindson Benjamin J. (Officer) Proposed Sale 5,734 shares at an average price of $13.32 for $76377.0. The insider now directly holds shares of 10x Genomics Inc (TXG).
